Table 2. Echocardiographic variables of patients.

		All patients (n=80)	Group 1 (n=23)	Group 2 (n=57)	p-value
Ejection fraction (%)		56.4±7.1	55.9±7.5	56.5±7	0.727
SPAP (mmHg)		33.4±12.2	30±8	34±13.2	0.195
Mitral valve, n (%)
	Native	77 (96.2)	22 (95.6)	55 (96.4)	0.847
	Prosthesis	3 (3)	1 (4)	2 (3)	0.113
Aortic valve, n (%)
	Native	71 (88.7)	18 (78.2)	53 (92.9)	0.692
	Prosthesis	9 (11.3)	5 (21.7)	4 (7)	0.059
TEE evaluation, n (%)
	Aortic vegetation	32 (40)	6 (26.1)	26 (45.6)	0.107
	Mitral vegetation	50 (62.5)	19 (82.6)	31 (54.4)	0.018
	Tricuspid vegetation	3 (3.7)	1 (4.3)	2 (3.5)	0.192
	Abscess	3 (3.7)	1 (4.3)	2 (3.5)	0.192
	Fistula	1 (1.25)	1 (4.3)	0 (0)	0.245
	Perforation	2 (2.5)	1 (4.3)	1 (1.7)	0.198
	Pseudoaneurysm	5 (6.2)	2 (8.6)	3 (5.2)	0.858
	Paravalvular leakage	5 (6.2)	2 (8.6)	3 (5.2)	0.125
	Prosthetic valve dehiscence	3 (25)	1 (16.6)	2 (33.3)	0.363
	Patients requiring surgery	13 (16.2)	4 (17.3)	9 (15.7)	0.287
Vegetation size (cm)
	Aortic valve	0.34±0.19	0.36±0.17	0.17±0.05	0.009
	Mitral valve	0.73±0.6	0.99±0.77	0.62±0.61	0.028

Statistically significant values are denoted in bold. Group 1: patients with stroke; Group 2: patients without stroke. SPAP: systolic pulmonary artery pressure; TEE: transesophageal echocardiography.